Biotech

All Articles

Turnstone gives up 60%, shakes up C-suite to stretch out cash money

.Turnstone Biologics is minimizing its head count through 60% and also shocking its own C-suite in o...

Gilead surrenders on $15M MASH wager after weighing preclinical data

.In a year that has observed an authorization as well as a boating of readouts for metabolic dysfunc...

Texas biotech axes cancer cells contract, pins really hopes on obesity

.Alaunos Rehabs is axing a deal along with Precigen, giving up licensing legal rights to a tailored ...

Capricor shares a lot more information for DMD treatment after triggering BLA

.Capricor Therapies is taking a victory tour for their phase 2 Duchenne muscle dystrophy (DMD) test....

FDA places Kezar lupus test in grip adhering to 4 person deaths

.The FDA has actually positioned Kezar Life Sciences' lupus test on hold after the biotech hailed fo...

Phase 3 Scholar Rock trial reaches SMA target, sending out stockpile 200%

.A phase 3 test of Academic Stone's spinal muscle degeneration (SMA) candidate has hit its major end...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream point out $182M strategy

.RNA biotech CAMP4 Therapies has actually marked out prepare for a $67 million IPO, with inflammatio...

Galecto purchases leukemia medication, loses bone tissue cancer possession in pivot

.A year after the failing of an idiopathic lung fibrosis applicant delivered Galecto on a hunt for s...

Judo throws down $100M to knock senseless kidney condition

.Taking the mat is actually Judo Biography, an ambitious biotech armed along with $one hundred milli...

AstraZeneca pays CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has actually paid off CSPC Pharmaceutical Team $100 million for a preclinical cardiovas...